SCHEMBL18133589

SCHEMBL18133589

C=C1NC=C(COC(=O)/C=C/C(=O)OCCc2c[nH]c(=O)[nH]c2=O)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17988542 0.94 — —
SCHEMBL17988562 0.92 CYP3A4 (0.30) —
SCHEMBL17988544 0.88 HTT (0.31) —
SCHEMBL18029528 0.81 HCAR2 (0.36) —
SCHEMBL17991891 0.81 HCAR2 (0.40) —
SCHEMBL17991875 0.76 HCAR2 (0.49) —
SCHEMBL17988554 0.76 HCAR2 (0.44) —
SCHEMBL17991872 0.75 HTT (0.36) —
SCHEMBL17991873 0.75 KMT2A (0.43) —
SCHEMBL17988566 0.75 HCAR2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9925191-B2 Fumarate compounds, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-03-27 — — US disclosed
US-20160297770-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-10-13 — — US disclosed
US-20160296522-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-10-13 — — US disclosed
Send feedback